Company

Theoria Science Co., Ltd.

Theoria Science develops exosome-based cancer diagnostic and therapeutic methods, including cancer screening tests.

About

Founded in 2012 and headquartered in Tokyo, Japan, Theoria Science Co., Ltd. develops exosome-based diagnostic and therapeutic methods for cancer, including cancer screening tests such as early detection of pancreatic cancer. It draws on nucleic acid medicines, bioimaging, stem cells and molecular oncology, and sells to healthcare providers, research institutions and pharmaceutical companies in Japan, North America and Europe. In August 2021 the company raised JPY 350.000 mn in Series A funding from SBI Investment.

2Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in